| abstract |
The present invention provides a pharmaceutical composition for use in the treatment or prevention of allergic diseases. More specifically, the present invention provides a pharmaceutical composition for use in the treatment or prevention of allergic diseases, which comprises a substance that induces B cell selective IgA class switching. As a substance that induces B cell selective IgA class switching, a PKC activator can be used. In addition, compositions containing substances that induce B cell selective IgA class switching may also be useful as mucosal adjuvants. |